SM
KTOVW

Sabby Management’s Kitov Pharma Ltd. Warrants KTOVW Stock Holding History

Sabby Management’s Portfolio KTOVW Stock Details KTOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,210,785
Closed -$944K – 353
2016
Q2 		$944K Buy
1,210,785
+1,096,065
+955% +$1.62M 0.05% 166
2016
Q1 		$126K Hold
114,720
– – 0.01% 272
2015
Q4 		$56K Buy
+114,720
New +$70.7K ﹤0.01% 305

Other funds holding KTOVW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sabby Management's KTOVW Position: Q3 2016 in Review

Sabby Management sold out of Kitov Pharma Ltd. Warrants (KTOVW) in Q3 2016, closing a stake of 1,210,785 shares — an estimated $944K sold.

Sabby Management first reported a position in KTOVW in Q4 2015 and held it in 3 quarters. The position peaked at $944K in Q2 2016. 5 funds tracked by Wall St. Rank hold KTOVW as of Q3 2016.

  • Sabby Management reported no remaining Kitov Pharma Ltd. Warrants position as of Q3 2016 after selling out during the quarter.
  • Sabby Management sold 1,210,785 Kitov Pharma Ltd. Warrants shares in Q3 2016, an estimated $944K.
  • Sabby Management first reported a position in Kitov Pharma Ltd. Warrants in Q4 2015 and held it in 3 quarters.
  • Sabby Management's Kitov Pharma Ltd. Warrants position peaked at $944K in Q2 2016.
  • 5 funds tracked by Wall St. Rank held Kitov Pharma Ltd. Warrants as of Q3 2016.

Based on Sabby Management's 13F filing for Q3 2016, filed 14 Nov 2016.